Aimmune Therapeutics, Inc.

NJ · United States · Reporting entity ID 100000776814

Total reported 2019–2025

$15.1M

#390 of 2,960 reporting companies — 0% of all reported industry payments

$5.50M in general payments across 80,705 records, plus $9.55M in research funding across 3,421 records.

How it breaks down

General payments $5,503,203

Research funding $9,553,798

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.